Literature DB >> 9537882

Improvement in CD4+ cell counts despite persistently detectable HIV load.

S M Levitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9537882     DOI: 10.1056/NEJM199804093381517

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Current concepts in human immunodeficiency virus infection and AIDS.

Authors:  S A Schwartz; M P Nair
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Repositioning HIV protease inhibitors as cancer therapeutics.

Authors:  Wendy B Bernstein; Phillip A Dennis
Journal:  Curr Opin HIV AIDS       Date:  2008-11       Impact factor: 4.283

3.  Replication-independent expression of anti-apoptosis marker genes in human peripheral blood mononuclear cells infected with the wild-type HIV-1 and reverse transcriptase variants.

Authors:  Prem L Sharma; Himabindu Chunduri; Jasen Wise; Rondeen Mindley; David Rimland
Journal:  Viral Immunol       Date:  2012-01-12       Impact factor: 2.257

4.  In vitro human immunodeficiency virus eradication by autologous CD8(+) T cells expanded with inactivated-virus-pulsed dendritic cells.

Authors:  W Lu; J M Andrieu
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation.

Authors:  Ozlem Equils; Alan Shapiro; Zeynep Madak; Chunren Liu; Daning Lu
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Direct effect of human immunodeficiency virus protease inhibitors on neutrophil function and apoptosis via calpain inhibition.

Authors:  Nurit Hadad; Rachel Levy; Francisc Schlaeffer; Klaris Riesenberg
Journal:  Clin Vaccine Immunol       Date:  2007-09-12

7.  Identifying the optimal dose of ritonavir in the treatment of malignancies.

Authors:  Emad Y Moawad
Journal:  Metab Brain Dis       Date:  2013-11-19       Impact factor: 3.584

8.  HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect.

Authors:  Caroline S Foo; Rana Abdelnabi; Suzanne J F Kaptein; Xin Zhang; Sebastiaan Ter Horst; Raf Mols; Leen Delang; Joana Rocha-Pereira; Lotte Coelmont; Pieter Leyssen; Kai Dallmeier; Valentijn Vergote; Elisabeth Heylen; Laura Vangeel; Arnab K Chatterjee; Pieter P Annaert; Patrick F Augustijns; Steven De Jonghe; Dirk Jochmans; Mieke Gouwy; Seppe Cambier; Jennifer Vandooren; Paul Proost; Christine van Laer; Birgit Weynand; Johan Neyts
Journal:  Antiviral Res       Date:  2022-04-04       Impact factor: 10.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.